BLACKSBURG, Va., April 13 -- Virginia Polytechnic Institute and State University issued the following news release:
Whenscientistswantthe Food and Drug Administration's (FDA) approval for a new treatment forcancers that start in thebonemarrow,theyreach out toKelly Norsworthy.
Norsworthyisthedirector of theDivision ofHematologicMalignanciesIin theFDA's Center for Drug Evaluation and Research. Shewill visit Virginia Tech'slaboratories inWashington, D.C.,on April 23toshare insightsontheregulation of targeted therapiesfor patients with myeloid malignancies.
As part of thevisit,Norsworthy willoffer graduatestudents an inside look into careers withthe FDA. They also will haveanopportunity toparticipate ina case study based on the approval of o...